SCHEMBL464655

SCHEMBL464655

CN(NC(=O)CS(=O)(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.68
HSP90AB1 P08238 1/20 0.68
ALDH1A1 P00352 7/20 0.41
MAPT P10636 5/20 0.41
HPGD P15428 4/20 0.35
LMNA P02545 3/20 0.35
HSD11B1 P28845 1/20 0.35
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
GAA P10253 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MMP3 P08254 2/20 0.33
HTT P42858 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
ALOX12 P18054 1/20 0.33
RECQL P46063 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL446362 0.93 HSP90AA1 (0.63) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD
SCHEMBL445761 0.93 HSP90AA1 (0.59) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD
SCHEMBL445596 0.93 HSP90AA1 (0.59) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD
SCHEMBL447212 0.90 HSP90AA1 (0.56) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD
SCHEMBL446749 0.90 HSP90AA1 (0.59) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD
SCHEMBL446377 0.89 HSP90AA1 (0.55) HSP90AA1HSP90AB1ALDH1A1MAPTLMNA
SCHEMBL447714 0.89 HSP90AA1 (0.55) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD
SCHEMBL450425 0.89 HSP90AA1 (0.55) HSP90AA1HSP90AB1ALDH1A1MAPTLMNA
SCHEMBL449018 0.89 HSP90AA1 (0.55) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD
SCHEMBL448996 0.89 HSP90AA1 (0.55) HSP90AA1HSP90AB1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9156783-B2 Compounds for treating proliferative disorders SYNTA PHARMACEUTICALS CORP. (US) 2015-10-13 US disclosed
US-9156783-B2 Compounds for treating proliferative disorders SYNTA PHARMACEUTICALS CORP. (US) 2015-10-13 US disclosed
US-20150025042-A1 Compounds For Treating Proliferative Disorders SYNTA PHARMACEUTICALS CORP. (US) 2015-01-22 US disclosed
US-20150025042-A1 Compounds For Treating Proliferative Disorders SYNTA PHARMACEUTICALS CORP. (US) 2015-01-22 US disclosed
US-8680100-B2 Sulfonylhydrazide compounds for treating proliferative disorders SYNTA PHARMACEUTICALS CORP. (US) 2014-03-25 US disclosed
US-8609720-B2 Compounds for treating proliferative disorders SYNTA PHARMACEUTICALS CORP. (US) 2013-12-17 US disclosed
US-20120065206-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2012-03-15 US disclosed
US-20100081635-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. 2010-04-01 US disclosed
US-20100081635-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. 2010-04-01 US disclosed
US-20100081635-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. 2010-04-01 US disclosed
EP-2057117-A2 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS Synta Pharmaceuticals Corporation (US) 2009-05-13 EP disclosed
WO-2008024303-A2 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081635-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS HSPB1, HSP90AB1, HSPA1B HSP90AA1 10/4885HSP90AB1 2/4885ALDH1A1 782/4885
US-20150025042-A1 Compounds For Treating Proliferative Disorders HSP90AB1, HSPB1, HSP90AB2P HSP90AA1 9/4885HSP90AB1 1/4885ALDH1A1 893/4885
US-20120065206-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS PKD1, PKD2, PCNA HSP90AA1 2300/4885HSP90AB1 1711/4885ALDH1A1 1351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.